ARTICLE Boosting Japanese Participation in Global Trials: New MHLW Guidance

ARTICLE Unlocking Immunotherapy's Potential with mRNA: Beyond the Blueprint

NEWS GV20 Therapeutics Trials GV20-0251 with KEYTRUDA®

PROJECTS Sandoz Invests EUR 50M in New Antibiotic Facility in Austria

PRESS RELEASE Alvotech Expands Access for New High-Concentration Biosimilar to Humira® in U.S.

TECHNO TRENDS RYBREVANT® Receives FDA Approval for Non-Small Cell Lung Cancer Combo Therapy

RESEARCH INSIGHTS Lipid-lowering Drugs and Osteoarthritis: New Insights from Mendelian Study